XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Stock Option Activity (Details) - 2017 Equity Plan and 2021 Equity Plan [Member]
 3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Employees And Consultants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Granted 138,489
Employees And Consultants [Member] | Non-Qualified Stock Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Outstanding Beginning 192,073
Weighted Average Exercise Price, Outstanding Beginning | $ / shares $ 8.94
Weighted Average Remaining Contractual Term, Beginning 7 years 7 months 6 days
Aggregate Intrinsic Value, Outstanding Beginning | $
Number of Options, Granted 138,489
Weighted Average Exercise Price, Granted | $ / shares $ 0.90
Weighted Average Remaining Contractual Term, Granted 8 years 4 months 24 days
Number of Options, Exercised
Weighted Average Exercise Price, Exercised | $ / shares
Number of Options, Forfeited/Cancelled (500)
Weighted Average Exercise Price, Forfeited/Cancelled | $ / shares $ 6.10
Weighted Average Remaining Contractual Term, Forfeited 8 years 10 months 24 days
Number of Options, Expired
Weighted Average Exercise Price, Expired | $ / shares
Number of Options, Outstanding Ending 330,062
Weighted Average Exercise Price, Outstanding Ending | $ / shares $ 5.57
Weighted Average Remaining Contractual Term, Outstanding Ending 7 years 7 months 6 days
Aggregate Intrinsic Value, Outstanding Ending | $
Number of Options, Exercisable Ending 304,972
Weighted Average Exercise Price, Exercisable Ending | $ / shares $ 5.59
Weighted Average Remaining Contractual Term, Exercisable Ending 8 years 2 months 12 days
Aggregate Intrinsic Value, Exercisable Ending | $
Directors [Member] | Non-Qualified Stock Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Outstanding Beginning 57,122
Weighted Average Exercise Price, Outstanding Beginning | $ / shares $ 9.44
Weighted Average Remaining Contractual Term, Beginning 6 years
Aggregate Intrinsic Value, Outstanding Beginning | $
Number of Options, Granted
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Remaining Contractual Term, Granted 0 years
Number of Options, Exercised
Weighted Average Exercise Price, Exercised | $ / shares
Number of Options, Forfeited/Cancelled
Weighted Average Exercise Price, Forfeited/Cancelled | $ / shares
Number of Options, Expired
Weighted Average Exercise Price, Expired | $ / shares
Number of Options, Outstanding Ending 57,122
Weighted Average Exercise Price, Outstanding Ending | $ / shares $ 9.44
Weighted Average Remaining Contractual Term, Outstanding Ending 5 years 8 months 12 days
Aggregate Intrinsic Value, Outstanding Ending | $
Number of Options, Exercisable Ending 57,122
Weighted Average Exercise Price, Exercisable Ending | $ / shares $ 9.44
Weighted Average Remaining Contractual Term, Exercisable Ending 5 years 8 months 12 days
Aggregate Intrinsic Value, Exercisable Ending | $